Association of dry skin with intercellular lipid composition of stratum corneum after erlotinib administration
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-020-04095-z
Abstract: Erlotinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, causes skin disorders such as dry skin, which impairs the skin barrier function. Stratum corneum (SC) lipids play an important role in skin barrier… read more here.
Keywords: erlotinib administration; dry skin; skin; intercellular lipid ... See more keywords